Supplementary Table 2. Site of vessel occlusion of included studies.
Study | Singh 2017 | Serles 2016 | Hu 2017 | Lecinana 2017 | Meinel 2019 | Weber 2019 | Lefevre 2014 | |
---|---|---|---|---|---|---|---|---|
PCO | BA | 25 (18.3%) | 40 (13.3%) | 24 (14.9%) | 52 (10.9%) | 165 (9.5%) | 118 (10.7%) | 25 (40.3%) |
VA | 3 (1.0%) | 15 (1.4%) | ||||||
PCA | 6 (0.5%) | 1 (1.6%) | ||||||
ACO | ICA | 51 (37.2%) | 60 (19.9%) | 42 (26.1%) | 100 (20.9%) | 1574 (90.5%) | 961 (87.4) | 9 (14.5%) |
M1 | 61 (44.5%) | 161 (53.5%) | 94 (58.4%) | 244 (50.9%) | 16 (25.8%) | |||
M2 | 28 (9.3%) | 40 (8.3%) | ||||||
ACA | 1 (0.6%) | |||||||
others | 9 (3.0%)# | 43 (9.0%)* | 11 (17.8%)* |
Note:
Represents others
Represents tandem occlusion; BA: Basilar artery; VA: Vertebral artery; PCA: Posterior cerebral artery; ICA: Internal carotid artery; M1: 1st segment of middle cerebral artery; M2: 2nd segment of middle cerebral artery; ACA: Anterior cerebral artery